BeOne Medicines Ltd. (ONC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$39.84M2016: -$89.51M2017: $12.75M2018: -$547.72M2019: -$750.27M2020: -$1.28B2021: -$1.30B2022: -$1.50B2023: -$1.16B2024: -$140.63M2025: $1.13B$1.13B
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$1.13B+901.8%
2024-$140.63M+87.8%
2023-$1.16B+22.7%
2022-$1.50B-15.2%
2021-$1.30B-1.2%
2020-$1.28B-71.1%
2019-$750.27M-37.0%
2018-$547.72M-4395.1%
2017$12.75M+114.2%
2016-$89.51M-124.7%
2015-$39.84M